Saturday 17 October 2026
Export CC’s income statement to Excel — free account
The Chemours Company
CC Basic Materials Specialty Chemicals
The Chemours Company’s revenue for fiscal 2025 (year ended December 2025) was $5.8 billion, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 1.49%, EPS grew 28.7%, free cash flow grew 128.0% and total debt fell 6.47%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
12.66
0.25
−1.94%
Follow CC
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
0.41 | 0.31 | 0.57 | 0.54 | |
P/FCF ratio |
0.00 | 34.73 | 21.57 | 14.23 | |
P/Operating CF |
16.31 | 12.93 | (75.49) | 19.64 | |
P/B ratio |
7.94 | 7.06 | 15.38 | 0.00 | |
Price to Tangible BV |
9.45 | 8.73 | 19.77 | 0.00 | |
EV/Sales |
1.01 | 0.90 | 1.18 | 1.09 | |
EV/EBITDA |
16.44 | 18.26 | 27.47 | 29.05 | |
EV/Operating CF |
22.33 | 19.85 | 20.77 | 15.88 | |
EV/FCF |
(739.76) | 102.75 | 44.78 | 28.92 | |
Quick Ratio |
0.83 | 0.80 | 0.82 | 0.85 | |
Current Ratio |
1.71 | 1.78 | 1.82 | 1.66 | |
Net Debt/EBITDA |
20.10 | 54.20 | 33.09 | (24.44) | |
Debt/Assets |
54.82% | 56.10% | 56.93% | 54.15% | |
Debt/Equity |
13.83 | 16.50 | 19.15 | (80.67) | |
Asset Turnover |
0.78 | 0.78 | 0.79 | 0.79 | |
Operating CF/Net income |
2.43 | (2.25) | 1.52 | (0.58) | |
Capex/Depreciation |
(0.41) | (0.63) | (0.60) | (0.54) | |
Interest Coverage |
1.38 | (0.28) | 0.38 | (3.13) | |
Research and Development Expense of Revenue |
1.74% | 2.03% | 1.88% | 1.70% | |
Selling, General and Administrative Expense of Revenue |
7.29% | 10.75% | 10.64% | 29.48% | |
Intangible Assets out of Total Assets |
0.01 | 0.01 | 0.01 | 0.01 | |
Share Based Compensation of Revenue |
0.33% | 0.30% | 0.51% | 0.44% | |
Graham Net Nets |
(1.71) | (2.33) | (1.24) | (1.32) | |
Graham Number |
0.00 | 0.00 | 0.00 | 3.69 | |
Earnings Yield |
(14.26%) | (21.03%) | (11.98%) | (9.31%) | |
Free Cash Flow Yield |
(0.34%) | 2.88% | 4.64% | 7.03% | |
Revenue per Share |
9.95 | 8.85 | 9.16 | 10.52 | |
Operating CF per Share |
0.97 | 0.91 | (0.29) | 1.04 | |
Capex per Share |
(0.23) | (0.35) | (0.32) | (0.29) | |
Free Cash Flow per Share |
0.75 | 0.57 | (0.62) | 0.75 | |
Cash per Share |
4.08 | 4.47 | 3.73 | 4.44 | |
Shareholders Equity per Share |
2.00 | 1.67 | 1.43 | (0.32) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
2.00 | 1.67 | 1.43 | (0.32) | |
Free Cash Flow |
112.00 | 85.00 | (93.00) | 114.00 | |
Working Capital |
1,327.00 | 1,315.00 | 1,319.00 | 1,233.00 | |
Capital Expenditures |
(34.00) | (52.00) | (49.00) | (44.00) | |
Net Current Asset Value |
(4,063.00) | (4,130.00) | (4,123.00) | (4,104.00) | |
EV/EBIT |
394.54 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.02 | 0.04 | 0.04 | 0.03 | |
Price to Operating Income |
158.74 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
949.00 | 724.50 | 808.50 | 933.00 | |
Average Payables |
1,052.00 | 1,055.00 | 948.50 | 980.00 | |
Average Inventory |
1,492.50 | 1,516.00 | 1,543.00 | 1,505.00 | |
Average Assets |
7,516.50 | 7,445.50 | 7,330.50 | 7,319.00 | |
Average Common Equity |
479.50 | 411.50 | 398.00 | 95.50 |
Columns are period end dates